SCHEMBL30262174

SCHEMBL30262174

CC(C)C[C@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)CC(=O)O)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)O)[C@@H](C)O

nearest known ligand 0.52

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
▸ KEAP1 Q14145 3/20 0.52
▸ IL23R Q5VWK5 1/20 0.47
▸ TFPI P10646 1/20 0.45
▸ RAMP3 O60896 6/20 0.45
▸ CALCR P30988 6/20 0.45
▸ GLP1R P43220 2/20 0.44
▸ ECE1 P42892 1/20 0.44
▸ MUS81 Q96NY9 1/20 0.44
▸ SCTR P47872 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30596157 0.92 KEAP1 (0.51) KEAP1IL23RTFPIRAMP3CALCR
SCHEMBL30084577 0.90 TFPI (0.48) KEAP1TFPIGLP1RECE1MUS81
SCHEMBL31303211 0.89 NPY4R (0.48) KEAP1
SCHEMBL31319515 0.88 RAMP3 (0.48) KEAP1TFPIRAMP3CALCR
SCHEMBL30596211 0.88 NPY4R (0.46) KEAP1TFPIRAMP3CALCRRXFP1
SCHEMBL30905693 0.87 TFPI (0.54) KEAP1TFPIGLP1RECE1MUS81
SCHEMBL30432641 0.87 TFPI (0.51) KEAP1TFPIGLP1RECE1MUS81
SCHEMBL29601319 0.87 RXFP1 (0.50) KEAP1TFPIGLP1RECE1MUS81
SCHEMBL29601022 0.87 RXFP1 (0.50) KEAP1TFPIGLP1RECE1MUS81
SCHEMBL30905699 0.86 TFPI (0.53) KEAP1TFPIGLP1RECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230040544-A1 COMPOSITIONS AND METHODS FOR RESTORING AND MAINTAINING THE DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX (DAPC) SAREPTA THERAPEUTICS, INC. 2023-02-09 — — US disclosed
Send feedback